Frontiers in immunology · 2026
Clostridioides difficile water-soluble zwitterionic lipoteichoic acid wsPS-III: structure, synthesis, and immunogenicity.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ma Zuchao, Pequegnat Brittany, Hodgins Douglas, Sagermann Martin, Ganeshapillai Jeyabarathy, Arar Sharif, Dawson Jamie, Frame Nolan W, Wheadon Samantha, Chow Herbert, Arroyo Luis, Monteiro Mario A
Аннотация
Clostridioides difficile polysaccharides (PSs) represent useful tools for the study of C. difficile pathogenesis. Water-soluble PS-I (pentaglycosyl-phosphate repeats) and PS-II (hexaglycosyl-phosphate repeats) and phenol-soluble lipoteichoic acid (LTA) PS-III have been previously identified. Most of the LTA PS-III repeats consist of two N-acetyl-glucopyranosamine (GlcNAc) units and glyceric acid (GroA), bridged by an exocyclic phosphodiester: →P-6)-α-D-GlcNAc-(1-3)-α-D-GlcNAc-[1-2-GroA]-(6→. Here, we describe a water-soluble PS from an equine C. difficile strain similar to PS-III, but with 6-substituted glucopyranosamine (GlcN) predominantly in the repeat: →P-6)-α-D-GlcN-(1-3)-α-D-GlcNAc-[1-2-GroA]-(6→ (coined wsPS-III). For analytical comparisons, the two saccharides, α-D-GlcN-(1-3)-α-D-GlcNAc-(1-2)-GroA and α-D-GlcNAc-(1-3)-α-D-GlcNAc-(1-2)-GroA, were chemically synthesized, and the transformation product, Gro-(1-P-6)-α-D-GlcNAc-(1-2)-GroA, was generated by Smith degradation. Pre-existing circulating IgG antibodies in horse sera due to natural exposure reacted with wsPS-III, and inoculation of rabbits with wsPS-III afforded IgG antibodies that reacted with C. difficile. It is postulated that the zwitterionic nature of wsPS-III is the driving force behind the observed solubility and immunogenicity. The glycans presented here will be useful in investigations concerning C. difficile biosynthetic pathways, virulence, antibiotics and vaccines.